Target Identification in Lupus - Renewal Grant Application

The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR’s Target Identification in Lupus Renewal (TILR) grants are now available online. Access the application directly at: https://proposalcentral.altum.com.

Please view the Program Guidelines for a full description.
Target Identification in Lupus Program Frequently Asked Questions .

Eligibility:

Current TIL recipients seeking to further their research may apply for a renewal grant for an additional 2 years for up to $275,000 per year. The renewal grant is awarded on a competitive basis. If awarded, this grant is considered a continuation of the original TIL Grant. The eligibility for application is as follows:

• At least one year and six months of project work (based on grant activation date) must have been completed at the time of the application for a renewal grant.
• A TIL Grant Renewal application can only be submitted once and has to be submitted on the next grant date after eligibility.
• The project must be in good administrative standing with the ALR at the time of submission (progress reports, financial reports, etc).

Guidelines for application and submission are also available on the website listed above.

Associated deadline dates are as follows:

Renewal Grant Applications :     Due to ALR on July 30, 2009

The ALR funds research that will accelerate the development of new treatments of lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus.

Individuals with doctoral degrees (MD, PhD or equivalent) are eligible to apply. Scientific independence, as evidenced by direction of a research program or a publication record or other experience that establishes scientific leadership, is necessary to apply. The ALR does not impose geographic restrictions on its applicants and investigators working anywhere in the world are eligible and encouraged to apply. The ALR is willing to appropriately support research in industry or collaborations between academia and industry; however, the ALR does not support clinical trials.

If you have any questions or require any additional information regarding the application process, please contact Diomaris Gonzalez, Assistant Director of Research Administration at 212-218-2840; 800-867-1743 or at dgonzalez@lupusresearch.org.